双环分层支架控释IL-17抗体促进伴糖尿病牙周骨再生的作用和机制研究
批准号:
82101078
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
刘君瑜
依托单位:
学科分类:
口腔颅颌面组织生物力学和生物材料
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
刘君瑜
中文摘要
糖尿病患者的过度炎症反应是牙槽骨愈合困难的重要因素,其体内IL-17的水平与骨破坏的程度呈正相关,是抗炎的关键靶点之一。基于血糖响应体系合理控释IL-17抗体是促进骨愈合的新方向。但目前该体系血糖响应灵敏度不足、药物活性不易保存且存在突释现象,本课题拟采用直接光处理3D生物打印技术来构建新型双环分层壳聚糖-生物玻璃支架,通过打印纤维环固定葡萄糖氧化酶体系并负载IL-17抗体,以期提高血糖响应性、抗体活性和改善突释等。重点考察酶活性、血糖响应性、释药曲线等关键参数;建立骨髓间充质干细胞高糖炎症模型,检测体系对细胞抗炎和成骨水平的作用;建立血糖控制不良的大鼠牙槽骨缺损模型,评价体系对骨缺损愈合的影响。本课题有望得到一种实时响应血糖控释IL-17抗体的载药体系,通过抑制局部炎症促进牙槽骨愈合,为糖尿病患者牙周或种植体周等裂隙型骨缺损提供符合临床实际的治疗策略,有助于探讨糖尿病牙槽骨愈合的机制。
英文摘要
The excessive inflammatory response in diabetic patients is a key factor for periodontal bone healing. IL-17 is identified as one of the significant anti-inflammatory targets, the level of which and bone destruction have a positive correlation. Rational controlled release of IL-17 antibody based on glucose response system provides a new way to promote bone healing. However, the system still exists some drawbacks such as insufficient glucose responsiveness, difficulty in long-term preservation of drug activity and burst release. In this study, a novel dual-looped layered chitosan-bioglass scaffold will be fabricated using direct light processing(DLP) 3D bio-printing technology. Specifically, the glucose oxidase system and IL-17 antibody will be fixed and loaded respectively by layered fibrous loops, in order to improve the glucose responsiveness, the activity of the antibody and avoid burst release. And then, firstly, the key parameters such as enzyme activity, glucose response and drug release curve will be investigated. After that, the scaffold will be co-cultured with bone marrow mesenchymal stem cells in the hyperglycemic inflammation medium to investigate on anti-inflammation and osteogenic process. At last, the model of diabetic rats with poor glucose control will be established. The scaffold will be implanted into the periodontal bone defect to evaluate the effect on bone healing. The aim of this study is to obtain a real-time glucose responsive drug delivery system to release IL-17 antibody, which is expected to promote periodontal bone healing by inhibiting local inflammation. This system provides a promising clinical strategy for fracturing type of bone defects of periodontal tissue or peri-implant, which is helpful to explore the mechanism of healing of alveolar bone in diabetes.
高血糖状态下异常的炎症反应是导致骨愈合的障碍,伴发糖尿病的牙周骨组织再生是临床上面临的挑战。IL-17是高血糖状态下的重要抗炎靶点,利用血糖响应载药体系“智能地”改变IL-17抗体的释放量,有利于达到高糖状态下抗体发挥作用需要的浓度,对抗高血糖环境带来的负面效应。但是血糖响应性载药体系尚存不足,主要体现在响应血糖的灵敏度有待提升,不合理的载药模式容易导致药物和酶活性丧失。因此本项目运用挤出式3D打印技术,将葡萄糖氧化酶GOx和IL-17抗体作为A组分,将过氧化氢酶CAT作为B组分,分层打印形成血糖响应性水凝胶支架。结果表明,1. 分层打印水凝胶支架在模拟高血糖的葡萄糖溶液中展现出明显的膨胀特性,其平均孔径为对照组的1.13倍,表现出良好的血糖响应性;2. 本项目持续探索材料的血糖响应机制,也就是一种高效的酶固定化方法,利用京尼平天然生物交联剂、EDC/NHS化学偶联固定、3D打印分层固定酶等方式制备不同形式的血糖响应支架,均取得良好的血糖敏感效果。本项目中将GOx和CAT两种酶进行合理的分层固定,提高GOx的活性,并最大程度地保存抗体活性;3. 负载IL-17抗体的分层水凝胶表面BMSCs的TNF-α和IL-6表达量随着时间推移而明显减少,而IL-10的表达水平显著增加,表明其可能通过抑制BMSCs的炎症反应促进组织修复,抗炎效果良好;同时细胞RUNX2,OPG和COL1-α的mRNA表达水平显著高于其他组,表明该材料对BMSCs的成骨分化具有更强的促进作用;4. 该支架修复早期糖尿病大鼠颌骨缺损时,与对照组相比,局部炎症细胞浸润程度有所降低,且胶原纤维含量显著增加,说明其能够早期促进糖尿病牙槽骨修复;5. 本项目还对3D多孔支架调节骨免疫微环境的机制初步探索,结果表明改变支架孔径可以调节巨噬细胞极化促进成骨,大孔支架组能够有效的促进巨噬细胞M2型极化促进骨修复。通过改变支架的物理结构可以调控免疫微环境促进骨再生。总之,分层打印的载药水凝胶支架增加了酶固定效率,提高支架的血糖响应性,在高糖环境中可以明显提高BMSCs的成骨分化能力,能够有效地在糖尿病大鼠中进行早期牙槽骨缺损修复,为糖尿病患者牙周炎、种植体周缺损等腔隙性骨缺损提供新的治疗思路,具有很大的临床应用潜力。
国内基金
海外基金